You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 1, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
Published on: April 28, 2019
1Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA.
This article details standardized methods for verifying dengue virus infection in laboratory mice. Researchers describe a precise technique to measure viral genetic material in blood and organs, alongside a visual staining approach to confirm active viral protein production within tissues. These protocols help ensure that animal models accurately reflect human disease progression.
15:25Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination
Published on: July 4, 2007
09:39Establishing Mouse Models for Zika Virus-induced Neurological Disorders Using Intracerebral Injection Strategies: Embryonic, Neonatal, and Adult
Published on: April 26, 2018
Area of Science:
Background:
No prior work had resolved the exact requirements for confirming viral replication in murine hosts. Researchers often struggle to validate infection models due to inconsistent detection of pathogen levels. It was already known that successful modeling requires clear evidence of systemic spread. That uncertainty drove the need for standardized verification techniques. Prior research has shown that viremia serves as a primary indicator of disease establishment. However, specific protocols for quantifying these markers remain sparse in current literature. This gap motivated the development of reliable detection strategies for laboratory settings. Establishing these benchmarks allows for more consistent evaluation of potential therapeutic interventions.
Purpose Of The Study:
The aim of this work is to establish standardized methods for validating dengue virus infection in mouse models. Researchers address the challenge of confirming productive viral replication within host tissues. This effort seeks to provide clear benchmarks for verifying systemic disease establishment. The team identifies a need for precise quantification of viral genetic material in blood. They also describe a visual approach to confirm protein production in organs. This study provides a framework for ensuring that animal models accurately represent human infection. By standardizing these procedures, the authors intend to improve the reproducibility of experimental results. The motivation lies in creating a reliable foundation for future pathogenesis and drug efficacy studies.
Main Methods:
Review approach focuses on established protocols for verifying viral presence in laboratory animals. Investigators detail a procedure for isolating and measuring genetic sequences from serum samples. The team utilizes specific probes to quantify pathogen concentration across various organ systems. Review approach also covers a fluorescence-based staining technique for identifying intracellular viral components. This visual strategy targets nonstructural markers to confirm active replication cycles. Researchers describe the preparation of tissue sections for microscopic examination. The analysis emphasizes the importance of standardized sample handling to ensure accurate results. This systematic overview provides clear instructions for implementing these diagnostic tools.
Main Results:
Key findings from the literature demonstrate that viremia verification is essential for confirming successful infection. The data indicate that quantitative assays reliably detect viral genetic material in both blood and tissue samples. Researchers report that fluorescence immunohistochemistry effectively highlights nonstructural protein localization within infected cells. These results confirm that the virus undergoes productive replication in the mouse host. The study shows that combining these two methods provides a comprehensive validation of the animal model. Findings suggest that consistent detection levels are achievable through these standardized procedures. The literature indicates that these metrics correlate with established disease progression markers. This evidence supports the utility of these techniques for rigorous model characterization.
Conclusions:
The authors propose that these standardized protocols improve the reliability of murine dengue research. Synthesis and implications suggest that quantifying genetic material provides a robust metric for infection status. Visualizing specific proteins confirms that the pathogen actively replicates within host cells. These combined approaches offer a comprehensive framework for validating experimental models. Researchers can utilize these techniques to ensure consistent disease progression across different studies. The findings imply that rigorous verification is necessary for translating animal data to human clinical contexts. Adopting these methods may reduce variability in future investigations of viral pathogenesis. This work provides a foundation for more accurate assessment of host-pathogen interactions.
The researchers propose a dual-verification strategy. They quantify viral genetic material in blood and organs while using fluorescence immunohistochemistry to visualize nonstructural protein production within host tissues. This confirms both systemic spread and active intracellular replication.
The authors utilize fluorescence immunohistochemistry to detect specific nonstructural proteins. This tool allows investigators to localize viral presence within cellular structures, providing visual confirmation of active replication that simple blood tests might overlook.
A quantitative assay is necessary to determine viral RNA levels. This technical requirement ensures that researchers can distinguish between transient exposure and productive, sustained replication within the host organism.
The authors employ viral RNA as a critical data type. This component serves as a direct indicator of viremia, allowing for precise measurement of the pathogen load in serum samples.
The researchers measure the presence of nonstructural proteins. This phenomenon indicates that the virus has successfully hijacked host machinery to produce its own components, confirming the model is biologically active.
The authors state that these protocols improve model consistency. They imply that standardized verification is a prerequisite for reliable drug testing and pathogenesis studies in future research.